We are live on ! Find out more
WSA

Wall Street Associates Portfolio holdings

AUM $151M
1-Year Est. Return 30.3%
This Fund
S&P 500
This Quarter Est. Return
+12.91%
1 Year Est. Return
+30.3%
3 Year Est. Return
+94.41%
5 Year Est. Return
10 Year Est. Return
AUM
$1.06B
AUM Growth
+$2.09M
Cap. Flow
-$58.5M
Cap. Flow %
-5.52%
Top 10 Hldgs %
16.9%
Holding
379
New
57
Increased
31
Reduced
195
Closed
48

Sector Composition

Rank Sector Weight
1 Healthcare 29.16%
2 Technology 23.34%
3 Consumer Discretionary 14.42%
4 Industrials 9.4%
5 Communication Services 4.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BELFB
126
Bel Fuse Inc Class B
BELFB
$4.21B
$2.13M 0.2%
+103,831
New +$2.14M
BDC icon
127
Belden
BDC
$5.19B
$2.1M 0.2%
25,836
-5,660
-18% -$496K
OESX icon
128
Orion Energy Systems
OESX
$80.6M
$2.08M 0.2%
82,790
-12,970
-14% -$380K
TEAR
129
DELISTED
TearLab Corporation
TEAR
$2.08M 0.2%
102,720
-1,400
-1% -$32.8K
MANH icon
130
Manhattan Associates
MANH
$11.4B
$2.07M 0.19%
34,632
-8,331
-19% -$461K
DXCM icon
131
DexCom
DXCM
$32B
$2.06M 0.19%
103,248
+26,384
+34% +$463K
VSTM icon
132
Verastem
VSTM
$592M
$2.04M 0.19%
22,533
-859
-4% -$90.8K
PRXL
133
DELISTED
Parexel International Corp
PRXL
$1.98M 0.19%
30,768
-6,851
-18% -$462K
EXAM
134
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
$1.94M 0.18%
49,633
-12,121
-20% -$499K
PFPT
135
DELISTED
Proofpoint, Inc.
PFPT
$1.93M 0.18%
30,291
-3,814
-11% -$224K
AVDL
136
DELISTED
Avadel Pharmaceuticals
AVDL
$1.92M 0.18%
90,731
-20,800
-19% -$373K
IMBI
137
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$1.89M 0.18%
70,125
+54,500
+349% +$2.6M
ACGN
138
DELISTED
Aceragen Inc
ACGN
$1.85M 0.17%
3,680
SCOR icon
139
Comscore
SCOR
$109M
$1.85M 0.17%
1,740
-763
-30% -$824K
CPHD
140
DELISTED
Cepheid Inc
CPHD
$1.85M 0.17%
30,234
-8,500
-22% -$485K
GIII icon
141
G-III Apparel Group
GIII
$1.5B
$1.85M 0.17%
26,236
-7,200
-22% -$441K
CBK
142
DELISTED
Christopher & Banks Corporation
CBK
$1.84M 0.17%
458,805
-626,395
-58% -$3.44M
FWRD icon
143
Forward Air
FWRD
$654M
$1.83M 0.17%
35,013
-8,201
-19% -$432K
MINI
144
DELISTED
Mobile Mini Inc
MINI
$1.83M 0.17%
43,426
-9,513
-18% -$390K
TNXP icon
145
Tonix Pharmaceuticals
TNXP
$192M
0
EEFT icon
146
Euronet Worldwide
EEFT
$2.7B
$1.77M 0.17%
28,762
-6,558
-19% -$390K
DPLO
147
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$1.74M 0.16%
+38,952
New +$1.47M
TILE icon
148
Interface
TILE
$2.22B
$1.74M 0.16%
+69,263
New +$1.53M
CGI
149
DELISTED
Celadon Group Inc
CGI
$1.71M 0.16%
82,600
-60,000
-42% -$1.48M
RCPT
150
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$1.7M 0.16%
+8,960
New +$1.48M

Similar funds

Wall Street Associates's Q2 2015 Portfolio in Review

As of Q2 2015, Wall Street Associates held 379 positions worth $1.06B, up 0.2% from $1.06B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Wall Street Associates withdrew a net $58.5M in Q2 2015, closing 48 positions and reducing 195 holdings. Its most notable exit was AUSPEX PHARMACEUTICALS INC COM STK (DE), an estimated $32.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Wall Street Associates opened a new position in iShares Russell 2000 Growth ETF worth $7.71M.

  • Wall Street Associates's largest Q2 2015 buy was iShares Russell 2000 Growth ETF: 49,900 shares worth $7.71M.
  • Wall Street Associates added most to Marcus & Millichap in Q2 2015, an estimated $3.39M increase.
  • Wall Street Associates's biggest Q2 2015 reduction was Repligen, cutting an estimated $8.82M.
  • Wall Street Associates fully exited AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q2 2015, selling an estimated $32.7M.
  • Wall Street Associates's ten largest holdings make up 17% of its $1.06B portfolio in Q2 2015.
  • Wall Street Associates opened 57 new positions and closed 48 in Q2 2015.
  • Wall Street Associates's portfolio value rose 0.2% quarter-over-quarter to $1.06B.

Based on Wall Street Associates's 13F filing for Q2 2015, filed 13 Aug 2015.